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Abstract 
 
Type I diabetes is an autoimmune disease resulting in the destruction of beta cells, the 
cell type in the body that produces insulin in the pancreas. Direct reprogramming can 
enable respecification of non-beta cells to produce insulin. The reprogramming vector, 
Ad-PNM, that expresses the genes Pdx1, Ngn3, and Mafa has reprogrammed non-beta 
cells of the pancreas and liver to produce insulin and restore normoglycemia in diabetic 
mice in vivo. Another possible approach is in vitro reprogramming with the same vector 
using cultured liver cells. Specifically, in this project biliary epithelial cells were isolated 
from mice, examined for Sox9 expression and treated with Ad-PNM to induce 
reprogramming.  
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Introduction 
1. Type I diabetes etiology, approaches to a cure  
Diabetes mellitus is a disease that results from an inability to maintain blood glucose 
homeostasis. This condition can occur because the body does not produce insulin (Type I) or 
because the body produces insulin, but cells are no longer responsive to insulin (Type II). 
The lack of insulin production in Type I diabetes (T1D) is caused when the immune system 
progressively kills beta cells in the pancreas. This progressively leads to diabetes because the 
only mature cell type in the human body known to produce insulin is the pancreatic beta cell.  
 Currently, there is no long-term cure for T1D. While diet and exercise also help 
manage T1D, exogenous insulin injections are required to regulate blood glucose levels. 
Most patients self-monitor glucose levels, measure and inject insulin (or an insulin-like 
compound) themselves; use an automated or programmable pump to regulate slower releases 
of insulin; and practice diet regimens.  
 Cures for type I diabetes could come from resolving the malfunctioning immune 
response or from introducing a permanent insulin-producing entity. Despite the advances in 
immunology in the late 20th century, preventing beta cell destruction is currently a less 
feasible approach than one compensating for lack of insulin. Thus far, the most successful 
attempts at a cure for T1D involve allogeneic transplants of whole pancreas and purified islet 
transplants (Type 1 Diabetes, 2014).  
 Successful islet transplants can stabilize a diabetic patient’s condition. However, 
allogeneic islet transplants are currently not a permanent solution: 50% of patients aged 18-
35 remained insulin independent 1 year after successful engraftment, and 50% of patients 
aged 35-<50 remained insulin independent 2 years after engraftment in North American, 
Australian, and European patients (CITR Seventh Annual Report, 2011). Transplanted 
patients most often become insulin dependent because the immune system will recognize the 
donor islets as non-self and attack them despite the regime of immunosupressive medication 
that accompanies the allogenic transplant. 
 T1D not only reduces quality of life, it also reduces the patient’s lifespan. Historically, 
individuals with T1D had reduced life expectancy of nearly 25 years, although recent studies 
have projected that current young adult T1D patients will live only 10-15 years less than their 
non-diabetic peers (Nainggolan, 2013). Despite recent clinical improvements in injectable 
  2 
insulins, islet transplants and medical devices such as insulin pumps and continuous glucose 
monitors, a permanent restoration of insulin production would restore the personal freedom 
and quality of life to the 30,000 people diagnosed every year in the US (Type 1 Diabetes 
Facts, 2015).  
 
2. Brief overview of liver development  
The development of endodermal organs is highly conserved in vertebrates. In mice, after 
formation of the three germ layers (ecto-, endo-, mesoderm), the endoderm undergoes spatial 
rearrangements resulting in three endodermal subregions including the fore-, mid- , and the 
hindgut (Zorn, 2008). In mice this definition occurs by E8. The lung, liver, pancreas, and gall 
bladder all develop from the foregut region of the endoderm.  
 In liver development, precursor cells (shown by lineage tracing studies) that commit to 
the hepatic lineage are initially surrounded by mesoderm stromal cells that include cardiac 
mesodermal cells. After changes in gradients of Wnt and Fgf4 signalling, these surrounded 
cells begin to express the homeobox family transcription factor, Hhex, and decrease laminin 
(Lam) expression and secretion (Zorn, 2008). Decreasing laminin secretion allows the 
progenitor cells increased mobility, allowing them to migrate away from contact with cardiac 
mesoderm. Enclosed in a new pocket of mesodermal cells, the region in which the newly 
migrated cells reside is termed the Septum Transversum (ST). At this point (E9.5 in mouse 
development), the newly relocated cells proliferate and along with contact-dependent 
signaling from the new mesoderm they alter their transcriptional programs, defining them as 
hepatoblasts (Zorn, 2008).  
 Once the hepatoblasts have proliferated to sufficient density and have formed defined 
outgrowths of cells, termed “chords”, the liver bud is said to have formed (Zorn, 2008). This 
time has been determined as E10.5 in mouse development, and coincides with the infiltration 
of hematopoietic cells. As the hepatoblasts continue to develop the architecture of the liver 
they express notable protein markers such as Epithelial Cell Adhesion Molecule (Epcam), α-
fetoprotein (Afp), and E-cadherin (Ecad) (Zorn, 2008).  
 Around E13 hepatoblasts in the liver bud express genes found in adult hepatocytes as 
well as bile duct cells, such as hepatocyte nuclear factor 4 (Hnf4), albumin (Alb); and 
cytokeratin 19 (Ck19), Hnf1β, respectively. By E14 differential expression patterns can be 
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seen histologically. Hepatoblasts most distal to portal veins do not express Sox9, and increase 
expression of genes such as Alb, Cebpa, Hnf1α, Hnf4α. These cells are considered committed 
to the hepatocyte lineage as time progresses they develop longer hepatic chords and mature to 
hepatocytes (Zorn, 2008).  
 Hepatoblasts most proximal to portal veins will maintain Sox9 expression and have 
lower expression of hepatocyte-specific genes. Such single cell layers that line the stroma of 
portal veins are termed a ductal plate. Ductal plate hepatoblasts notably express osteopontin 
(Opn), Epcam, Ck19 in addition to Sox9. Previously, cells identified in this location were 
considered committed to the bile duct/cholangiocyte lineage (Zorn, 2008).  
 At approximately E18 in mice (a few days before birth), distinct populations of 
hepatocytes and cholangiocytes are detectable with architecture similar to that observed in 
the livers of adult animals. This maturation of sheets of cells near ductal plates ultimately 
develops into the intrahepatic hepatocyte-surrounded bile duct tracts throughout the lobes of 
the liver (Figures 2, 3, 4).  
 
 
Figure 1. Lineage commitment of ductal plate cells. Ductal plate cells differentiate into bile 
duct cells. Adapted from Zorn,(2008). 
 
3. Developmental relatedness of pancreas and liver 
 The liver and pancreas develop from the definitive foregut endoderm and their 
precursor populations diverge during mid-gestation in mice. Their divergence is largely due 
to relative proximity to the cardiac mesoderm and ST as well as the notochord. After the 
nascent organs have accumulated significant mass, liver and pancreatic precursor cells begin 
differentiating toward more specialized cell types recognized in the mature animal, and it is 
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at this time that Sox9 expression is detected in each organ during late gestation. Sox9 
expression was long thought to define ductal plate cells as committed bile duct cells in the 
liver. Sox9, Hnf1b, and Ngn3 co-expression is observed in cells that later become pancreatic 
endocrine and pancreatic ductal cells. Because of the similar Sox9 expression in late 
gestation, and the common foregut endodermal origin of the liver and pancreas, it is plausible 
that Sox9 expression could be an important factor in converting a liver cell program to a 
pancreatic cell program and vice versa.    
 
4. Basic liver biology  
The liver is known to be a highly regenerative organ as well as metabolically active organ. 
Hepatocytes comprise the liver parenchyma and make up the 80% of organ volume 
(Miyajima, A., Minoru, T., & Itoh, T., 2014). Another other major cell type of endodermal 
origin in the liver is the biliary epithelial cell (BEC) or bile duct cell (BDC). Mesoderm-
derived cells include endothelial cells lining the vasculature and sinusoidal endothelial cells 
lining the fenestrations of the basolateral side of hepatocytes, hepatic stellate cells, 
lymphacytic pit cells and Kupffer cells (lumenal macrophages) (Tanaka, M., Itoh, T., 
Tanimizu, N., & Miyajima, A., 2011 ).  
 As polarized epithelial cells, hepatocytes take up various compounds (nutrients, toxins, 
metabolites, etc) through their basolateral side. Blood flows along their basolateral side after 
entering the liver from the small intestine and from whole body circulation; these blood 
supplies enter via the portal vein and hepatic artery respectively. The flow of blood along the 
basolateral side of hepatocytes (as well as that of BECs) moves from the portal vein and 
hepatic artery towards the central vein. In contrast, the flow of bile (the main product 
secreted by hepatocytes) flows along the apical side of hepatocytes and moves toward bile 
ducts (Figure 2). Before bile is transported through the tubular biliary network, bile duct cells 
will absorb and secrete ions to modify the bile that enters the gall bladder (Yang et al., 2010). 
The region in which extensions of the portal vein, hepatic artery, and intrahepatic bile ducts 
are clustered is called a portal triad. 
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Figure 2. Activity within liver lobule. Blood enters the liver through extensions of the hepatic 
artery and portal vein and a central vein collects blood that runs along hepatocytes. 
Hepatocytes metabolize and secrete various compounds from and to the blood supply as well 
as produce bile that is secreted and flows toward the bile ducts. Adapted from 
http://www.daviddarling.info/encyclopedia/L/liver.html 
 
 
 
Figure 3. Liver lobule structure. A central vein is equidistant from 6 portal triads that 
contain extensions of the portal vein, hepatic artery and bile duct tracts. Adapted from 
http://mkk.szie.hu/dep/aeet/tanweb/liver/liver0/liver.html 
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Figure 4.Vessel organization within the liver. Branches of the hepatic artery, hepatic vein, 
portal vein, and bile duct extend throughout the lobes of the liver. Adapted from 
http://profmohammadali.com.bd/pioneerhepa.php 
 
5. Rationale for reprogramming to “beta-like” cells  
Stem cells are cells that have the ability to 1) self-renew indefinitely and 2) have the capacity 
to differentiate (adopt a more specialized phenotype). Stem cells exist along a spectrum, with 
regards to mammalian species, the zygote is the first cell of any organism. The zygote is 
totipotent in that it can become all cells of the embryo and the extra-embryonic tissue that 
facilitates growth of the embryo inside the uterus. At the other end of the spectrum is an adult 
stem cell, such as the satellite cell, which can only replace a few cell types, e.g. muscle fibers 
and more satellite cells.  
 Study of totipotent cells was documented as early as the 1880s (De Robertis, 2006). 
However, most recent studies focused on human pluripotent stem cells are based on the work 
with embryonic stem cell (ESC) lines initiated by Jamie Thomson and induced pluripotent 
stem cells (iPSCs) reported by Shinya Yamanaka and colleagues. Work with pluripotent stem 
cells (cells that can differentiate into any cell type of the embryo) has introduced new 
potential approaches to cure diseases that arise from dysfunctional cell activity: whether 
disease-associated cells are aged, metabolically abnormal, or even selectively destroyed by 
the immune system. The idea behind such cures is that the ability to control the end 
phenotype of a multipotent cell provides a reserve population of ‘healthy’ cells that can 
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displace or replace a disease-causing population. This healthy reserve population can be 
directed through identity change toward a more differentiated, specialized cell type of 
interest. 
 In changing the identity of any particular cell the overarching questions become: what 
is the starting cell type and what is the end goal?  One answer has been to start with 
undifferentiated, pluripotent cells that are either embryonic stem cells or iPSCs. The end goal 
has often been the differentiated cell type that is damaged in a disease, such as a neuron, 
hepatocyte or cardiomyocyte (Shi, Y., Kirwan, P, & Livesey, F. J., 2012; Cai et al., 2012; 
Lian et al., 2013).     
 Another approach to changing cell identity has been directly reprogramming a mature, 
differentiated cell type into another mature, differentiated cell type without a stable 
progenitor (e.g. pluri- or multipotent) intermediate. Advantages may include shorter timelines 
and less cell loss in the process of manipulating the population; these aspects are particularly 
useful for implementing the product as a cell-based therapy. Direct reprogramming has been 
demonstrated in vivo as well as in vitro using virally delivered transgenes and transgene-free, 
chemical/protein combinations (Richard et al., 2011; Masuda et al., 2013) .  
 Direct reprogramming has also been implemented in the development of a T1D cure. 
Ideally, cells from the same patient or from a donor would be converted to a stable cell type 
that produces insulin to replace that critical function of beta cells that is most damaging in 
Type I diabetes. There are several potential starting cell types that are related to beta cells, 
including other endocrine cells of the pancreatic islet: alpha, delta, and pancreatic-
polypeptide (PP-) cells (Steiner et al., 2010).  Due to the embryonic formation of foregut 
endoderm organs, the cells of the gall bladder and liver, in addition to non-beta cells of the 
pancreas, all provide developmentally relevant cells for possible reprogramming into a stable 
insulin-producing cell. 
 Using transcription factors to reprogram cells may require relevance to an organ’s 
developmental biology. For re-specification towards a beta cell identity, the most successful 
candidates have been Pancreatic-Duodenal Homeobox 1 (Pdx1), Neurogenin 3 (Ngn3), and 
V-Maf Avian Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Mafa). Pdx1 drives 
the early pancreatic program in the early pancreatic epithelium, it induces expression of 
Insulin, Glut2, Nkx6.1, Nkx2.2. Ngn3 is expressed during neuronal and pancreatic 
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development. Ngn3 expression promotes pancreatic progenitor cells commit to non-exocrine 
lineages. Mafa is expressed in mature beta cells and is considered critical to beta cell identity 
and insulin expression.  
 In 2008, Zhou et al. showed that infecting mouse pancreatic tissue with 3 separate 
adenoviruses encoding Pdx1, Ngn3, and Mafa sequences was effective in converting 
amylase+CK19-insulin- exocrine cells to insulin+c-peptide+ beta-like cells  in vivo (Zhou et al, 
2008). 
 Akinci et al. (2012) cloned the genes for Pdx1, Ngn3 and Mafa into a single adenovirus 
vector, referred to as Ad-PNM (Figure 5). Tail-vein injection of Ad-PNM into NOD-SCID 
mice localized Ad-PNM infection to liver cells and was found to produce ectopic ducts 
containing insulin+, c-peptide+ cells (Banga et al., 2012). Furthermore, the Slack laboratory 
found that injection with Ad-PNM was also able to stably reverse diabetes for 4 months in 
treated NOD-SCID mice.  
 Newport Green dye was used to isolate insulin-containing cells from whole liver single 
cell suspensions 12 weeks after Ad-PNM administration (Banga et al., 2012). Newport Green 
is a fluorescent molecule that has an affinity for zinc which is necessary to form insulin 
granules in beta cells. After fluorescence activated cell sorting (FACS) for Newport Green 
dye, the group conducted a RT-PCR-based expression study. This showed more than fifteen-
fold increases in Insulin1, Insulin2, and endogenous Pdx1 expression in Newport Green+ 
cells compared to the relative expression of these genes in Newport Green- cells.  A ten-fold 
difference could be seen for beta cell-specific transporter, Slc30a8, endoderm marker, Sox17, 
and five-fold difference for Glut2, among other beta cell and endocrine-specific genes. The 
expression analysis demonstrated transcriptional changes present in the cells as a result of the 
Ad-PNM-reprogramming.       
 
Figure 5. Ad-PNM construct. Pdx1, Ngn3, and Mafa sequences were cloned into one 
single stranded vector. 2A peptide sequences ensure 3 independent peptide sequences are 
produced from one polypeptide. Adapted from Banga et al. (2012)   
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 The Slack group’s data suggested that using a gene therapy construct like Ad-PNM 
could provide a Type I diabetes therapy using non-pancreatic starting cell types.The liver is a 
healthy, highly regenerative organ that can serve as an autologous or allogeneic starting cell 
source.  
 The Slack group also examined the starting identity of reprogrammed cells. 
Immunostaining of sections from mice sacrified at 12 weeks post infection demonstrated 
ectopic ductal cells were absent of the hepatocyte protein albumin and expressed the bile duct 
cell marker, cytokeratin 19 (Ck19).  Immunostaining further indicated that insulin+ ectopic 
ductal cells were often also Sox9+.  The group then used Cre-mediated lineage tracing to 
label Sox9+ ductal plate cells in Sox9-CreERT2;mTmG reporter mice injected with tamoxifen 
at E15.5. Histological sections of adult mice showed that the labelling in these experiments 
was highly specific to bile duct cells of the liver and immunostaining of these sections 
showed that some of the lineage-labelled (mGFP-expressing) bile duct cells continue to 
express Sox9 in the adult mouse (Banga et al., 2012).  
 Additional information about the reprogramming process came from experiments using 
the peroxisome-proliferator-activated receptor α, γ (PPARα, γ) agonist, WY14643 (Banga et 
al., 2014). The Slack group administered Ad-PNM via tail vein injections into 
immunocompetent mice with a CD1 background. WY14643 was added to the animals’ chow 
for 4 days. After gene delivery the total time before sacrifice was either 1 or 6 weeks.   
 1 week after Ad-PNM administration, hepatocytes and ductal cells were observed to be 
insulin+, WY14643 treatment resulted in EdU labelling of hepatocytes and bile duct cells, and 
EdU incorporation was associated with Sox9-expressing cells (Banga et al., 2014). 6 weeks 
after Ad-PNM administration, insulin+ cells included only those within ductal structures, 
expressing bile duct and beta cell markers such as Ck19, EpCAM, and c-peptide, 
respectively. 
 Despite a lack of immunohistochemical data demonstrating co-expression of Sox9 and 
Insulin or Sox9 and Ad-PNM genes in the same cells at 1 week post infection, the above 
results suggested that successful reprogramming with Ad-PNM is increased with actively 
cycling, Sox9-expressing, periportal ductal cells. Due to the low frequency of insulin+ ductal 
cells 6 weeks post-infection, it appears that only rare cell populations of the periportal bile 
duct region will stably express Insulin after Ad-PNM infection. 
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 Collectively, the data with the NOD-SCID mice and CD1 mice given WY14643 
suggest that periportal ductal cells and hepatocytes can be reprogrammed after virus 
administration, however cells that undergo stable reprogramming after 6 and 12 weeks have a 
ductal morphology. Additionally, reprogramming efficiency is influenced by active cell 
cycling.  The possible origin of cells that stably express Insulin and other endocrine genes at 
6 and 12 weeks post viral administration include a bipotent resident Sox9+ progenitor cell, 
cycling hepatocytes or BECs, and/or periportal hepatocytes and BECs already in an altered 
state. The data from the Slack Lab and recent work evidencing resident Sox9-expressing cells 
in the adult mouse liver suggest that the origin of stably reprogrammed cells is a ductal 
bipotent progenitor (Banga et al., 2012; Furuyama et al., 2009).  
 From the previous studies, this thesis work aims to address: First, can Sox9+ ductal 
cells be isolated from mouse liver and cultured? Second, can they be reprogrammed in vitro 
into stable beta-like cells that produce insulin? The answers to these questions intend to 
provide proof of principle evidence that a liver-based, autologous biopsy-transplant ex vivo 
reprogramming regimen is a possible Type I diabetes cure. 
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Methods 
1. Liver Ductal Cell Harvest 
C57BL/6 background, Sox9-CreERT2;mTmG mice and CD1 mice were used in experiments. 
They were housed in the McGuire Translational Research Facility at the University of 
Minnesota and cared for by the Research Animal Resources (RAR) staff under The 
University of Minnesota Animal Care and Use Committee guidelines.   
 Sox9-CreERT2;mTmG mice were labelled with tamoxifen in utero at E18.5 by 
intraperitoneal injection of mothers with 3mg tamoxifen dissolved in sunflower seed oil. 
Labelled mice were sacrificed at 6-8 weeks of age. To preserve the health of cells in tissues, 
particularly in highly perfused organs like the liver, mice were sacrificed by cervical 
dislocation according to IACUC guidelines. Liver removal shortly followed.  
 
2. Liver digestion, ductal cell isolation 
Livers were removed within 10 minutes of sacrifice and transferred to a BSL2 hood in 10cm 
petri dishes . Within 20 minutes of sacrifice removed livers were minced with scalpels until 
tissue was smooth and uniform. Each adult liver was placed in 50mL of dissociation buffer 
(10mM HEPES with pH 7.4, 5mM KCl, 0.5mM EGTA, 5mM Glucose, 1X 
penicillin/streptomycin (from 100X stock), 1X anti/anti (from 100X stock), 250mM 
gentamicin in Earle’s Buffered Salt Solution (EBSS)) and placed in a 37°C water bath for 50 
minutes, with shaking agitation every 5-10 minutes. Tissue was then centrifuged for 6 
minutes at 900 rpm. Pellets were resuspended in 25mL of digestion buffer (1.67mg/mL 
collagenase type II (Invitrogen), 1.33mg/mL bovine hyaluronidase (Sigma Aldrich), 5% 
FBS,1X anti/anti, 1X penicillin/streptomycin, 250mM gentamicin in DMEM:F12). Tissue 
was incubated again in a 37°C water bath and inverted as well as mixed with a pipet every 10 
minutes. After 45-50 minutes 1.34units/mL of dispase (BD Biosciences) were added and 
liver contents incubated for 30-40 minutes longer in a 37°C water bath. Pellets were washed 
4 times in 40X volumes of washing media (5% FBS, 1X anti/anti, 1X 
penicillin/streptomycin, 250mM gentamicin in DMEM) with centrifuging settings at 1000 
rpm for 5 minutes. Pellets were then treated in one of two ways : 
1)   Resuspension in complete Keratinocyte-Serum Free Medium (Life Technologies; 
250mM gentamicin, 1X anti/anti, 1X penicillin/streptomycin) for 1-2 days suspension 
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culture in 2 wells of ultra-low attachment plate (Corning) , collected and resuspended 
in 15 % FBS Williams E medium (supplemented with 20ng/mL hEGF, ITS-X, 
250mM gentamicin, 1X anti/anti, 1X penicillin/streptomycin, 1X NEAA) for an 
additional 1-2 days in suspension culture. 
2)   Resuspension in 15% FBS Williams E medium for 1-2 days followed by suspension 
culture in complete KSFM for 1-2 days suspension culture.  
The two methods of suspension culture were used to assess whether one mitigated 
mesenchymal cell co-culture better than the other. No difference was observed. Ductal cell 
aggregates were formed in suspsenion culture 3-4 days after isolation. After one of the two 
suspension culturing methods, contents of wells were collected and filtered through 37µm 
reversible PES filters (StemCell Technologies) with sterile PBS. The large fraction, >37µm, 
was centrifuged at ~1000 rpm for 5 minutes, resuspended and plated.  
 
3. Ductal cell culture 
For infection, immunostaining or in suspension for recollection, cells were plated in 15% 
FBS Williams E medium and were kept in a 37˚C, 5% CO2 incubator. Media was changed 
every 2 days unless necessary to change daily in wells with larger cell numbers.  
 For plating cells in collagen sandwiches, 2-3mg/mL rat tail Type I collagen (Millipore) 
stock was used to make the 3D matrix. Ice cold Type I collagen stock was diluted into a tube 
of 10X Williams E and 0.34N NaOH with a ratio of 8:1:1 respectively. Approximately 20% 
of well volume was initially plated; after the matrix solidified a cell suspension was added. 
Cells adhered overnight and the next day media was removed and the second half of ~20% 
well volume was added. The homogenous mixture was aliquoted to 6-well plates so that once 
a sandwich was complete, the volume of each well was 40% full with matrix. After 
solidification 1.5-2mL of media were added. Purified cells from one liver were plated in 1 or 
2 collagen sandwiches of a 6-well plate to allow space for population expansion.  
 For passaging cells out from collagen, serum-containing media was removed and 2mL 
of 20mg/mL Type I collagenase (Worthington) was added. Cells were incubated for 15-20 
minutes with pipet agitation until the collagen matrix was disassembled. Cells were washed 5 
times with 40x media volume in 10% FBS DMEM washing media. The final pellet was 
resuspended in plating media, gently mixed with a pipet and plated onto first layers of 
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collagen I matrix in new wells at a 1:2 dilution.  
 
4. Ad-PNM infection 
Dutton Lab Batch A4 virus was amplified and titered by Caitlin Hill, MS.  Batch A4 led to 
the highest levels of Pdx1 and Insulin expression in treated AR42J-B13 cells cells, a rat 
exocrine cell line (Longnecker et al., 1979), with 90% of cells coexpressing Pdx1 and Insulin 
(Hill, 2014). The titer was determined to be 1.2 x 1011 infectious units/mL (ifu/mL).  
 Aggregated cells were treated with 0.25% Trypsin/EDTA for 5 minutes before being 
transferred to wells of 6-well type I collagen-coated BioCoat plate (Corning BioCoat 
Cellware) before infection. They were then incubated with 1µg/mL polybrene (PB) for 5 
minutes. As the optimum titer of Ad-PNM virus for primary mouse liver cells was unknown, 
virus was added in one of three stock dilutions:10-3,10-5,10-6 . ‘No PB, no virus’ and ‘no 
virus’ controls were used. ‘No PB, no virus’ controls were used in addition to ‘no virus’ 
controls to evaluate any toxicity of polybrene. No toxicity was observed. No virus controls 
were used to examine whether Ad-PNM was the cause of any Pdx1 and Insulin expression. 
All controls showed no Pdx1 or insulin by immunostaining. Cells were incubated for 2 days 
after which cells adhered and the media was changed. 
 
5. Immunostaining 
Aggregated cells were plated on BioCoat plates for immunostaining post isolation and post 
infection. Cells were washed twice with PBS and fixed with 10% formalin for 10 minutes. 
10% formalin was removed and cells were washed three times with PBS-T. Cells were either 
covered with PBS and placed in 4˚C for storage or permeabilized with 0.2% Triton-X100 
PBS for 20 minutes at room temperature (RT). Cells were blocked with 5% donkey serum, 
0.5% BSA, PBS-T for 30-40 minutes at RT.  Antibodies were added at respective dilutions to 
1% BSA PBS-T (Table 1). Incubation with primary antibodies occurred overnight at 4˚C, and 
with secondary antibodies at RT covered on the benchtop for 1 hour. Cells were washed three 
times with PBS-T between antibody incubations and finally covered in PBS. DAPI 
(10mg/mL stock) was added to each well at a 1:1000 dilution. Cells were imaged using 
inverted microscope Leica DMI 6000B. 
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Table 1. Primary antibodies and dilutions 
Primary Dilution 
Millipore rabbit Anti-Sox9  1:1000, 1:5000 
Santa Cruz goat Anti-Cytokeratin 19  1:75-1:50 
chicken Anti-Vimentin  1:1000  
SCBT rat E-cadherin   1:75 
Millipore rabbit Anti-Pdx1  1:1500 
Abcam guinea pig Anti-Insulin  1:250 
 
Table 2. Secondary antibodies and dilutions 
Secondary Dilution 
Alexa Fluor 488 donkey anti-rabbit 1:500 
Alexa Fluor 555 donkey anti-goat 1:500 
Alexa Fluor 633 goat anti-chicken  1:500 
Alexa Fluor 488 goat anti-guinea pig 1:500 
Alexa Fluor 488 donkey anti-rat 1:500 
 
  15 
Results 
1.Use of Sox9-CreERT2:mTmG mouse 
Several studies using chronic injury models and viral infection for lineage-tracing have 
revealed a proliferative, ductal cell-like population that expresses Sox9 near the portal triad. 
The interpretation was that the observed cells are a reactivated Sox9-expressing resident 
progenitor population in adult liver of at least rats and mice that is bipotent and able to give 
rise to hepatocytes and BECs. Based on this idea of a Sox9+ liver stem/progenitor cell 
(LSPC), embryonic lineage tracing was used by Banga et al. (2012) to investigate whether 
the successfully reprogrammed cells were progeny of a once Sox9-expressing parent 
population. In uninfected reporter mice labelled at E15.5, mGFP+Sox9+ ductal cells were 
present. Subsequently, in labelled mice treated with Ad-PNM ectopic ductal cells were 
mGFP+insulin+ (Banga et al., 2012).  Based on these data, possible target cells for stable 
reprogramming in adult mice are ductal progeny of embryonic Sox9-expressing liver cells, 
specifically BECs and, if present, LSPCs. Hence, embryonic labelling of Sox9-reporter mice 
was continued for in vitro infection with Ad-PNM to examine reprogramming in ductal cells 
of Sox9- lineage. If Sox9-expressing LSPCs with ductal morphology are present in adult 
mouse livers, these cells would be isolated along with BECs.    
 At E15.5, ductal plate cells (a late-stage hepatoblast population) begin their final stages 
of committing to the ductal lineage. At the time of the initial experiments with Ad-PNM, it 
was commonly thought that between E15 and E18 hepatocytes and BECs are committed, and 
BECs as well as LSPCs are established from ductal plate cells. To label Sox9-expressing cells 
at late gestation, pregnant mothers were injected with tamoxifen at E18.5 for convenience. 
Labelling with tamoxifen injection at E18.5 will not label all bile duct cells as some Sox9-
expressing progenitors presumably have committed to non-Sox9-expressing bile duct cells by 
this time.   
 
2. Ductal cell isolation and initial cell culture 
After the isolation procedure, initial suspension cultures showed that not all cells in 
aggregates were labelled (mGFP+) indicating that they were not progeny of cells labelled by 
Sox9 driven CreER expression at E18.5 (Figure 6). Additionally, not all aggregates were free 
from ‘contaminating’ co-culturing mesenchymal cells after 1-2 days of suspension culture in 
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serum-free media.  
 Aggregates were purified after filtering with a 37µm strainer, however batch-to-batch 
variation did not allow a consistent understanding of co-culturing cell levels (Figure 7). 
 
 
Figure 6. Labelled and unlabelled ductal aggregate cells in suspension. Lineage-labelling 
was done by tamoxifen injection at E18.5. Adult livers were digested, aggregated cells 
filtered and cultured in suspension. (A) Pre-filtration, not all ductal aggregates contain 
labelled (mGFP+) cells. (B) A typical aggregate is shown. Cells are 3 days post isolation.  
Red= mTomato, Green= mGFP. Scale bars= 50µm 
 
 
A B 
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Figure 7. Aggregates before and after filtration. Aggregates 3 days (A,B) and 4 days (C,D) 
post isolation, pre (A,C) and post (B,D) filtration with 37µm strainer. Magnified views of 
aggregates pre- (E) and post (F) filtration. Scale bars= (A-D) 250µm, (E,F) 50µm 
 
3. Short-term culture on collagen I coated surface 
As enzymatic digestion is crude and no FACS or MACS system was used to select for Sox9-
A B 
C D 
E F 
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expressing and/or ductal cells, immunostaining after cell enrichment (suspension culture 
followed by filtration) was used to survey the identity of cells. For immunostaining the cells 
were plated on Corning BioCoat plates which are coated with a thin layer of type I collagen.  
 Characterization of the populations described the relative proportion of putative LSPCs 
based on commonly used markers: Ck19 and Sox9. Fixation for immunostaining was 
performed 5-7 post isolation.    
 Despite batch-to-batch variation, plated aggregates contained many Sox9+ cells, 
however the relative proportion of Sox9+ cells per isolation was not quantified (Figures 
8,9,10). The morphology of Sox9+ cells was mostly ductal with some mesenchymal cell co-
culturing (Figure 8). Interestingly, some cells with tightly defined cell borders exhibited 
more discriminate Sox9 immunostaining. An incidence of more discriminate Sox9 
immunostaing in tight epithelial cell clusters could indicate that widespread Sox9 detection in 
less tightly packed epithelial cells is evidence of stress from the isolation procedure and 
dedifferentaion upon culturing (Figure 9B,D). E-cadherin (Ecad) and Sox9 immunostaining 
was done as well, Ecad expression was weak however present, this may be due to an old 
secondary antibody (Figure 9).  Ck19 co-stained with Sox9 in cells with epithelial 
morphology (Figure 10). No Ck19+ cells were found to be Sox9-. 
 Based on the morphology of the flat, extended Sox9+Ck19+ cells the question arises 
whether culturing induces dedifferentiation and if so, do plated Ad-PNM infected cells 
experience dedifferentiation that significantly alters the ability of cells to reprogram 
compared to in vivo Ad-PNM infection? Immunostaining for other BEC-specific antibodies 
might be used and qRT-PCR done with lysates of isolated aggregates to look for stress 
response and biliary gene expression, and verify Sox9 and Ck19 expression. 
 Though less specific, suspension culture is possibly a less stressful isolation method 
than MACS or FACS. A less stressful procedure encourages the preservation of cell identity 
and may better serve in vitro reprogramming. However, the methods used here are 
inconclusive regarding the viability and purity of cells post-isolation. The isolated cells in the 
aggregates are mostly Sox9+Ck19+ with ductal morphology, however variable morphology 
would seem to indicate differences in the identity/health of the early culture popoulations.   
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Figure 8. Characterization of adherent aggregate cells with immnostaining. (A,C,E) Phase 
images of aggregates show ductal morphology and compact groups of cells. (B,D,F) Sox9+ 
cells are surrounded by co-culturing fibroblasts. Cells analyzed 5 days post isolation.     
Red= Sox9, Green= Vimentin. Scale bars= (A,B)250µm, (C-F)50µm 
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Figure 9.Epithelial characterization of adherent aggregate cell with immunostaining. 
(A,C,E,G) Phase images of adherent aggregate cells. (B,D,F,H) Weak E-cadherin detection 
in Sox9+ cells. Cells analyzed 7 days post isolation. Red= Sox9, Green= E-cadherin. Scale 
bars= 50µm 
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Figure 10. Ductal characterization of adherent aggregate cells with immnostaining. (B,D) 
Phase images of adherent aggregate cells. (A,C,E) Cytokeratin 19+ ductal cells are Sox9+. 
Cells analyzed 6 days post isolation. Red= Cytokeratin 19, Green= Sox9. Scale bars=50µm 
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4. Infection of short-term cultured cells 
Treatment of cells with Ad-PNM was performed with aggregates 3-4 days post isolation. 
Short-term infection was defined as culturing cells for 7 days or less after exposure to the 
virus (11 days or less post isolation). The outcome determining successful infection was 
Pdx1protein detection and for successful reprogramming detection of insulin protein by 
immunostaining. Corning BioCoat plates were used for plating infected cells.  
 Upon examining mGFP (embryonically labelled using Sox9 CreER ) and mTomato 
(unlabelled)-expressing cells for any bias in infection rates, there was no observable 
difference in Pdx1 expression 5-7 days after infection (Figure 11 A,B,D). This observation 
was seen in several rounds of infection. There was no observable toxicity from polybrene 
administration, and no Pdx1 expression was detected in ‘no virus’ controls.  
 The 10-5 virus dilution was found to maximize infection with minimal cell loss (by 
visual observation).  Reflective of the variable sizes of ductal cell aggregates, Pdx1 detection 
varied from 0.7% to 18.1% of counted cells, with higher percentages correlating with smaller 
patches of cells (Table 3). The groups of cultured cells used for counting contained at least 
100 cells. A lack of consistently sized and dissociated aggregates inherently led to an 
inconsistent MOI among cells within the same aggregate and among all the cells in a well. 
Inconsistent cell numbers and inconsistent MOI are significant barriers to assessing infection 
rates.  
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Table 3. Counts of Pdx1-expressing cells 
Percent Pdx1+ Cells counted 
7.5% n= 106 
18% n= 155 
4.3% n= 208 
1.4% n= 208 
2.2% n= 230 
2.1% n= 237 
1.7% n= 348 
5.0% n= 421 
0.7% n= 429 
1.8% n= 446 
5.3% n= 469 
Table 3. Counts of Pdx1-expressing cells after infection with 10-5 dilution of Batch A4 Ad-
PNM virus. Mean average= 5.4% , Range=0.7-18% . Aggregate cells were infected in 
suspension, cells were analyzed by immunostaining 5 days after cells adhered to plates. Data 
from cells isolated from two mice  
 
 Despite detection of Pdx1 expression at 5 and 7 days after infection, no insulin was 
detected in cells from 3 different mice infected with Ad-PNM.  It is possible that the culture 
conditions inhibited efficient reprogramming and/or insulin expression would not occur until 
more than 7 days after infection. Additionally, dissociation of the aggregates would allow 
increased access of virus to all cells (to increase MOI), however dissocation disrupts the cell-
to-cell contacts normally experienced by epithelial cells. This disruption may affect the 
reprogramming of ductal cells.        
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Figure 11. Infection of adherent aggregate cells. Upon infection aggregates were 3-4 days 
post isolation, infected cells adhered to the plate surface by 6 days post isolation, and 
fixation occurred 11 days post isolation. (B,C, D) Pdx1 is expressed in lineage-labelled 
(mGFP+) and unlabelled (mTomato+) cells. (A,E,F) Phase images show morphology of 
infected cells. Red=mTomato , Green= mGFP, Magenta= Pdx1, Blue= DAPI.  
Scale bars= (C,F)50µm, (A,B,D,E)100µm 
 
5. Long-term culture: duct-forming cells 
Expansion of target cells would likely be necessary for a clinically relevant ex vivo 
A B 
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reprogramming procedure. This could be done before reprogramming or after. To gauge the 
difficulty of expanding before reprogramming, long-term culturing of isolated liver cells was 
attempted. After ductal cell collection, a Type I collagen matrix was used for 3D culture of 
aggregates.    
 A simple Type I collagen matrix and a previously used epithelial cell culture medium 
formulation led to expansion of cells in a collagen “sandwich”. Passaging was done 
infrequently, once a month, and culturing of populations was done for up to 6 months.  
 As no expression levels were measured nor proteins labeled with immunostaining, the 
identity of the cells after 5 or 6 months is unknown. 3D culturing encouraged tubular 
extensions (Figure 12). Morphology of mGFP-expressing (Sox9 lineage-labelled) cells was 
not distinctly different from that of mTomato-expressing (unlabelled) cells. Passaging 
encouraged growth and tubular structures that are consistent with duct-forming epithelial cell 
cultures (Sirica, A. E., & Gainey, T. W., 1997) .  
 Cells from one isolation procedure experienced a great deal of stress in their first 
month of 3D culturing (Figure 12A,B,C,E; Figure 13). Less cellular debris and mesenchymal 
cells were removed and cells were mixed with the ‘wet’ collagen mixture before the matrix 
was formed. These cells also experienced less frequent media changes in their first month of 
culture, approximately once a week. However, they were able to be passaged four times into 
type I collagen sandwiches and continued to proliferate. Cultures appeared to decrease their 
doubling time with each passage. Small hollow strucures were observed that contained 
unlabelled (mTomato+) cells after 6 months of culture (Figure 13). It is possible that cells 
from the original aggregates were enriched for a robust, proliferative ductal cell population.  
 The culturing techniques used allowed expansion and formation of ductal structures 
within a Type I collagen matrix. Nonetheless culturing the cells in a less dynamic and 
complex system is likely to lead to gene expression changes that through many passages may 
induce larger phenotypic changes. To encourage conservation of starting cell identity, more 
physiologically accurate culture conditions should include choosing a matrix with more liver-
specific ECM proteins, e.g. Type IV collagen and laminin, as well as a matrix that is matched 
to liver ECM mechanics/mechanical forces and additional soluble factors added to the 
medium.  
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Figure 12. Long-term 3D culture of ductal aggregate cells. (A,B,C) Branched structures with 
hollow ductal extensions formed after 2 months of 3D culture in Type I collagen matrix. (D) 
Cellular extensions can be seen 2 weeks after passaging (3 months of 3D culture). (E) 
Passaged cells from the culture shown in (A-C) continue to form branched structures after 6 
months of culture. No morphological differences were observed in labelled (mGFP+) and 
unlabelled cells (mTomato+). Red=mTomato, Green=mGFP. Scale bars= (C,D) 50µm, (E) 
250µm 
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Figure 13. Ductal structures reform after multiple passages. (A,C,E) Unlabelled (mTomato-
expressing) ductal cells proliferate and form hollow structures after fourth passage, 6.5 
months of 3D culture in Type I collagen matrix. (B,D,F) Phase. Scale bars= 50µm  
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Discussion 
1. Efficacy of ductal cell isolation, in vitro short-term reprogramming 
The crude methods described allow predominantly Ck19+Sox9+ ductal cells to be collected as 
aggregates 3 days after isolation from whole livers. The relative porportion of Ck19+Sox9+ 
ductal cells was inconclusive and multicellular aggregates contained both Sox9 lineage-
labelled and unlabelled ductal cells. Labelled and unlabelled cells maintained the capacity to 
form ductal structures and proliferate after months of culturing in a 3D Type I Collagen 
matrix.  The identity of cells after long-term culturing is unknown, however it is possibly 
altered due to lack of a physiologically matched matrix and soluble factors in the medium.    
 Ad-PNM infection of ductal aggregate cells occurred with a range of 0.7-18.1% Pdx1+ 
cells. Variability in infection rates among ductal aggregates was most likely due to variability 
in aggregate size. The vitality of these cells is uncertain in vitro as well as the degree of 
reprogramming. Insulin expression was not observed in cells that were treated with Ad-PNM 
and cultured for 7 days. In vitro reprogramming efficiency may be improved by changing the 
matrix on and in which cells are cultured, as well as by culturing cells longer, and examining 
them for insulin expression 10 and 14 days after infection.   
 
2. Identity of reprogrammable population, resident Sox9+ cells? 
It was clear from the work of the Slack Lab (Banga et al., 2012; Banga, et al., 2014) that Ad-
PNM can reprogram some cell type(s) in adult mouse livers yielding sufficient insulin 
secretion to reverse diabetes in NOD-SCID and immunocompetent mice. However, the 
evidence is unclear what starting cell types are most permissive to reprogramming toward a 
beta-like state. Knowing these cell types would be useful for establishing populations to be 
infected for ex vivo reprogramming as well as would contribute to the understanding of liver 
biology.  
 Coexpression of Sox9 and Insulin and lack of Albumin expression from histological 
data was shown in mice 10 days after Ad-PNM delivery in vivo; gene expression data was 
analyzed from samples taken 12 weeks after Ad-PNM delivery (Banga et al. 2012). It has 
been documented that virally-infected cells can change expressional programs in timespans 
less than one week (Dorn et al., 2005) and replication-deficient adenovirus vector infection 
alters cytoskeletal dynamics (Luo et al., 2006; Warren, J. C., Rutkowski, A., & Cassimeris, 
  29 
L.,2006;, Zamir et al., 2007) which over time can affect intracellular signalling in pathways 
that influence transcriptional regulation (Kumar et al., 2007). Hence data regarding cell 
identity at even 1 week post infection may be uninformative of the cell’s orginal phenotype.  
 Additionally, in Banga et al. (2014) an immune response was observed to lower 
reprogramming rates in CD1 mice compared to NOD-SCID mice. Given that immune cells 
and non-hematopoietic liver cells were encountering the same transgenic virus, and that viral 
infections in vivo induce immune cell and infected cell antiviral responses, then an immune 
cell response observed by the group likely indicates that infected liver cells also reacted to 
Ad-PNM virus itself. Intracellular virus detection alone alters cellular transcriptional 
programs in addition to the influence of the introduced genes Pdx1, Ngn3, and Mafa, further 
influencing the transcriptional changes from the starting cell type.  
 Recently, the existence and prevalence of a resident Sox9+, bipotent LSPC has been 
questioned (Grompe, 2014).  Work by Carpentier et al. (2011) demonstrated heterogeneity in 
the progeny of Sox9+ labelled ductal plate cells. The group showed that Sox9+ cells labelled 
at E15.5 contributed to intrahepatic and extrahepatic BECs as well as periportal hepatocytes. 
Demonstration of  labelling by Banga et al. (2012) also shows that not all lineage-labelled 
cells are still expressing Sox9 nor appear to be in a bile duct in the uninfected adult control 
Sox9-CreERT2;mTmG mice. Additionally, histological data from Banga et al. (2012) and 
(2014) lacks clear tissue architecture, e.g. the portal vein and hepatic artery of the portal triad, 
for anatomical context of ductal structures and progeny of labelled cells.   
  Work by Yanger et al. (2014), Tarlow et al. (2014), and O’Neill et al. (2014) 
support the possibility that stably reprogrammed cells could be hepatocytes. Yanger et al. 
(2014) used Cre-based lineage-tracing methods to determine the major cell type that 
repopulates the liver after injury from four different methods: CDE diet, DDC diet, CCl4 
injection, and ANIT treatment. They labelled cytokeratin 19 (Krt19)-expressing bile duct 
cells in Krt19-CreER;R26R-YFP transgenic mice. In separate experiments hepatocytes were 
labelled by infecting R26R-lsl-YFP mice with an adeno-associated virus serotype 8 (AAV8) 
encoding a thyroid-binding globulin (TBG) promoter sequence upstream of that encoding 
Cre recombinase, specifying hepatocyte expression of Cre recombinase (Yanger et al., 2014).  
Examing recovered livers revealed little to no contribution of Krt19 lineage-labelled cells to 
the hepatocyte population. Complementary to that result, recovered livers showed no 
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decrease in labelled hepatocytes, suggesting little to no contribution from or ‘crowding out’ 
by an unlabelled, non-hepatocyte cell type. This group provided significant evidence to 
discredit the existence of a LSPC in adult mouse livers.  
 Tarlow et al. (2014) generated liver chimeras such that mTomato-labelled FAH+/+ 
hepatocytes repopulated the livers of unlabelled FAH-/- mice. The group showed that 6 weeks 
after 0.1% DDC diet-induced injury, EdU-incorporating, OPN+ biliary-like cells were found 
that also expressed mTomato, demonstrating that donor hepatocytes entered the cell cycle and 
adopted a biliary identity. Sorting of mTomato+ cells also expressing “oval cell” marker, 
MIC1-1C3, revealed that the biliary-like cells derived from donor-hepatocytes also had much 
higher levels of Sox9, CK19, EpCam, Spp1 expression and much lower levels of HNF4α and 
albumin expression compared to hepatocytes. Additionally, they generated chimeras with 
Sox9-CreERT2;mTmG FAH+/+ donor hepatocytes in unlabelled FAH-/- mouse livers. DDC 
diet-induced injury occurred over 6 weeks with one low dose of tamoxifen for Sox9-specific 
labelling.  Livers examined at the end of 6 weeks demonstrated mGFP+, oval cell marker 
A6+, FAH- cells. Because these cells were mGFP-expressing they were known to be 
hepatocytes at the time of injury and by 6 weeks after the start of injury they expressed Sox9 
and A6. The group demonstrated the capacity of hepatocytes to adopt a Ck19, Sox9-
expressing psuedo-biliary identity after chronic injury/stress.  
 O’Neill et al. (2014) examined the process of hepatocyte dedifferentiation in culture. 
The group labelled hepatocytes in Alb-Cre;R26R LacZ mice. X-gal was used for hepatocyte 
identification to demonstrate the purity of their population after perfusion isolation.  After 3 
days of culture in DMEM medium, a medium known to induce dedifferentiation of 
hepatocytes, Sox9 was one of the genes distinctly upregulated. Additionally, Sox9 protein 
levels were increased when compared to cells cultured in keratinocyte serum-free medium 
(KSFM), a medium known to retain hepatocyte identity. Overexpression of Sox9 led to 
modest increases in Ck19 and OPN expression compared with freshly isolated hepatocytes. 5 
days of culture in DMEM lead to observational increases in Sox9 and OPN immunostaining. 
The group provided evidence that environmental changes such as changes in culture media 
can induce Sox9 expression in cultured hepatocytes, and that Sox9 expression was an early 
event in the transdifferentiation of hepatocytes toward a OV6, Ck19, OPN, Sox9-expressing 
biliary-like cell.  
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 Hence there is evidence to support the possibility that the target cell type 
reprogrammed by Ad-PNM and observed in Banga et al., 2012, 2014, could result be an 
injured/stressed hepatocyte. As there are metabolic differences among hepatocytes (Kang et 
al., 2012),  it is possible that one type versus the other is more sucseptible to Ad-PNM 
reprogramming.  
 Also to consider when re-examining the work of Carpentier et al. (2011) as Sox9+ 
ductal plate cells give rise to extrahepatic BECs  there remains the possibility that these are 
another reprogrammable cell type of liver origin. Recent work has demonstrated that a small 
fraction of extrahepatic BECs express insulin in neonatal and adult mice (Dutton et al., 
2007). Histology from Banga et al. (2012) and Banga et al. (2014) demonstrate that some of 
the insulin+ ducts are large and could represent reprogrammed extrahepatic ducts of the hilar 
region. 
 In vivo data have not excluded the possibility that stressed hepatocytes and extrahepatic 
BECs contribute to stably reprogrammed, insulin+ ductal cells in livers after exposure to Ad-
PNM. Hence, in vitro reprogramming should include treating primary hepatocytes and 
extrahepatic BECs with Ad-PNM.  
 Experiments in this thesis work showed that the protocol used here could reliably 
isolate ductal cells of the mouse liver and that these cells can be infected in vitro in 
suspension culture upon exposure to Ad-PNM. They were shown to be infected and 
expressing Ad-PNM genes after 5 days, however at this time were not observed to be 
producing insulin protein.  Further experiments specifically isolating intrahepatic BECs and 
extrahepatic BECs of the hilar region could continue to explore reprogramming efficiency 
and timelines in vitro for the two liver ductal cell populations. With more physiologically 
accurate culturing surfaces and 3D matrices, the infection efficiency and insulin production 
may be improved, as well as expansion of the cells.  Excitingly, Ad-PNM virus remains a 
potential means to develop a system of in vivo or in vitro reprogramming toward a stable, 
insulin-producing state using cells of healthy tissue in T1D patients and non-patients.   
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